<DOC>
	<DOCNO>NCT00553176</DOCNO>
	<brief_summary>The purpose study evaluate long-term clinical , economic humanistic outcome various treatment regimen , include infliximab , Crohn 's disease real world medical practice .</brief_summary>
	<brief_title>The Crohn 's Therapy , Resource , Evaluation , Assessment Tool Registry</brief_title>
	<detailed_description>The TREAT ( The Crohn 's Therapy , Resource , Evaluation , Assessment Tool ) registry prospective , observational , multicenter , long-term registry feature clinical , economic , humanistic measure characterize treatment Crohn 's disease . The physician track treatment patient outcomes least 5-year period . Physicians expected manage patient would normal practice condition . No predefined schedule visit medical procedure require . Data collect semi-annual basis physician document assessment disease severity , medication use , adverse event . Upon enrollment , patient complete health assessment questionnaire . As observational study , study drug administer . Through course Registry , analyse performed support submission health authority , question academic interest .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Patients must diagnose Crohn 's Disease Patients participate clinical trial Crohn 's disease condition also eligible enrolled TREATâ„¢ Registry Patients unable participate program 2 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Infliximab</keyword>
	<keyword>Immune disorder</keyword>
	<keyword>Remicade</keyword>
	<keyword>Registry</keyword>
	<keyword>Crohn 's Disease</keyword>
</DOC>